If you take
antidepressant citalopram hydrobromide..read full article & discuss with
your Doctor
New VA Study Takes Issue with FDA's Warnings about Citalopram
ANN ARBOR, MI - For nearly two years, the Food and Drug Administration has been issuing safety advisories about the risks of abnormal heart rhythms with higher doses of the antidepressant citalopram hydrobromide. A new study out of the Ann Arbor VAMC and the University of Michigan raises questions about the FDA’s actions, however. In an article published by the American Journal of Psychiatry, researchers reported finding no increased risk for abnormal heart rhythms or death in patients who took daily doses of more than 40 mg before or after the original 2011 warning took effect.
More
http://www.usmedicine.com/psychiatry/new-va-study-takes-issue-with-fdas-warnings-about-citalopram.html
New VA Study Takes Issue with FDA's Warnings about Citalopram
ANN ARBOR, MI - For nearly two years, the Food and Drug Administration has been issuing safety advisories about the risks of abnormal heart rhythms with higher doses of the antidepressant citalopram hydrobromide. A new study out of the Ann Arbor VAMC and the University of Michigan raises questions about the FDA’s actions, however. In an article published by the American Journal of Psychiatry, researchers reported finding no increased risk for abnormal heart rhythms or death in patients who took daily doses of more than 40 mg before or after the original 2011 warning took effect.
More
http://www.usmedicine.com/psychiatry/new-va-study-takes-issue-with-fdas-warnings-about-citalopram.html
No comments:
Post a Comment